SBIR/STTR Research Award

Short Wavelength UV LEDs Based on Bulk Nitride Substrates

Award identifier 8dc3b414eb629140a95ebcb691b2d08a8b25b58d88a4f92f2c74de3b94988614Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Crystal IS, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Modern biomedical instrumentation relies on ultraviolet (UV) light sources to implement a broad range of detection techniques. The long-term goal of the proposed effort is the development of solid-state UV light emitting diodes (UV LEDs) as a replacement for existing lamp sources at wavelengths shorter than 360 nm, where commercial solid-state devices do not exist. The proposed approach is based on the fabrication of UV LEDs in the aluminum gallium nitride (AIGaN) material system on a recently-developed bulk single-crystal aluminum nitride (AIM) substrate. The unique properties of this AIM substrate, including its close lattice- match to AIGaN alloys and its exceedingly low defect density, enable the manufacture of LEDs with shorter wavelength, higher efficiency, higher brightness, and longer lifetime than those fabricated on alternative substrate materials. The Phase I program is to design and demonstrate a UV LED with emission at 340 nm. A novel epitaxial structure in the AIGaN system will be designed, modeled, grown and characterized. Then devices will be fabricated and tested. At the 340 nm wavelength and shorter, such UV LEDs will offer improved efficiency, compactness, reliability, and cost relative to existing lamps, enhancing the performance and utility of biomedical research tools and perhaps fostering a new generation of compact microfluidic instruments. Ultimately, this will enable a greater understanding of the biological mechanisms that underlie human health, the discovery of new therapies and diagnostics, and more precise control of pharmaceutical manufacturing processes and drug quality.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.